HOGA1
Basic information
Region (hg38): 10:97584323-97612802
Previous symbols: [ "C10orf65", "DHDPSL" ]
Links
Phenotypes
GenCC
Source:
- primary hyperoxaluria type 3 (Definitive), mode of inheritance: AR
- primary hyperoxaluria type 3 (Supportive), mode of inheritance: AR
- primary hyperoxaluria type 3 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hyperoxaluria, primary, type III | AD/AR | Renal | Increased fluid intake in order to promote hydration as well as medical therapy (eg, neutral phosphate therapy, citrate medications, thiazides) may be beneficial | Biochemical; Renal | 20797690; 21896830; 22781098; 22688746; 22391140 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (26 variants)
- Primary hyperoxaluria type 3 (18 variants)
- HOGA1-related disorder (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HOGA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 122 | 125 | ||||
missense | 36 | 62 | 108 | |||
nonsense | 10 | 15 | ||||
start loss | 3 | |||||
frameshift | 14 | 13 | 27 | |||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 16 | 17 | ||||
splice region | 1 | 1 | 3 | 23 | 1 | 29 |
non coding | 40 | 59 | 16 | 115 | ||
Total | 34 | 70 | 104 | 186 | 19 |
Highest pathogenic variant AF is 0.00151
Variants in HOGA1
This is a list of pathogenic ClinVar variants found in the HOGA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-97584425-G-A | Primary hyperoxaluria type 3 | Benign/Likely benign (Nov 12, 2018) | ||
10-97584480-G-A | Primary hyperoxaluria type 3 | Uncertain significance (Jan 12, 2018) | ||
10-97584705-T-G | Pathogenic (Jul 25, 2023) | |||
10-97584706-G-A | Primary hyperoxaluria type 3 | Pathogenic (Oct 27, 2023) | ||
10-97584706-G-T | Pathogenic (Jul 22, 2021) | |||
10-97584709-G-GGGTCT | Primary hyperoxaluria type 3 | Pathogenic/Likely pathogenic (Feb 24, 2023) | ||
10-97584712-T-C | Likely benign (Dec 03, 2021) | |||
10-97584721-C-T | Primary hyperoxaluria type 3 | Likely benign (Nov 01, 2023) | ||
10-97584723-G-C | Primary hyperoxaluria type 3 | Uncertain significance (Oct 27, 2023) | ||
10-97584724-GTCT-G | Primary hyperoxaluria type 3 | Uncertain significance (Dec 19, 2017) | ||
10-97584733-G-A | Likely benign (Sep 25, 2021) | |||
10-97584736-G-A | Likely benign (Dec 03, 2021) | |||
10-97584736-G-T | Primary hyperoxaluria type 3 | Uncertain significance (Mar 02, 2022) | ||
10-97584742-G-A | Primary hyperoxaluria type 3 | Conflicting classifications of pathogenicity (Jan 04, 2024) | ||
10-97584742-G-T | Likely benign (Mar 12, 2021) | |||
10-97584744-T-A | Primary hyperoxaluria type 3 | Uncertain significance (Oct 27, 2023) | ||
10-97584745-A-G | Likely benign (Jul 09, 2023) | |||
10-97584754-C-T | Likely benign (Jan 31, 2024) | |||
10-97584757-G-A | Likely benign (Mar 28, 2023) | |||
10-97584766-T-C | Likely benign (Jul 30, 2023) | |||
10-97584767-G-A | Primary hyperoxaluria type 3 | Uncertain significance (Dec 18, 2019) | ||
10-97584768-TG-T | Primary hyperoxaluria type 3 | Pathogenic (Feb 17, 2020) | ||
10-97584769-G-A | Likely benign (Jul 20, 2021) | |||
10-97584772-G-A | Likely benign (Aug 16, 2023) | |||
10-97584778-G-A | Pathogenic (Jan 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HOGA1 | protein_coding | protein_coding | ENST00000370646 | 7 | 28480 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.58e-14 | 0.00373 | 125677 | 1 | 70 | 125748 | 0.000282 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.279 | 217 | 206 | 1.05 | 0.0000128 | 2115 |
Missense in Polyphen | 81 | 77.025 | 1.0516 | 787 | ||
Synonymous | 0.710 | 75 | 83.2 | 0.901 | 0.00000538 | 686 |
Loss of Function | -0.874 | 19 | 15.3 | 1.24 | 8.32e-7 | 155 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000521 | 0.000518 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000943 | 0.000925 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000267 | 0.000264 |
Middle Eastern | 0.000943 | 0.000925 |
South Asian | 0.000429 | 0.000392 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the final step in the metabolic pathway of hydroxyproline. {ECO:0000269|PubMed:20797690, ECO:0000269|PubMed:21998747}.;
- Disease
- DISEASE: Hyperoxaluria primary 3 (HP3) [MIM:613616]: A disorder phenotypically similar to hyperoxaluria type 1 and type 2. It is characterized by increase in urinary oxalate excretion and mild glycolic aciduria. Clinical manifestations include calcium oxalate urolithiasis, hematuria, pain, and/or urinary tract infection. {ECO:0000269|PubMed:20797690}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Arginine and proline metabolism - Homo sapiens (human);Glyoxylate and dicarboxylate metabolism - Homo sapiens (human);Metabolism of amino acids and derivatives;Metabolism;4-hydroxyproline degradation;Glyoxylate metabolism and glycine degradation
(Consensus)
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- rvis_EVS
- -1
- rvis_percentile_EVS
- 8.32
Haploinsufficiency Scores
- pHI
- 0.0918
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.516
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hoga1
- Phenotype
- homeostasis/metabolism phenotype; renal/urinary system phenotype; liver/biliary system phenotype;
Gene ontology
- Biological process
- glyoxylate catabolic process;4-hydroxyproline catabolic process;oxalate metabolic process;pyruvate biosynthetic process;glyoxylate metabolic process
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- protein binding;4-hydroxy-2-oxoglutarate aldolase activity;protein homodimerization activity